WHO WE ARE
The Peripheral Nerve Society is an international non-profit organization of scientists, physicians, and other healthcare providers working together to investigate and treat diseases of the peripheral nervous system.
OUR MISSION
To improve the lives of people with peripheral neuropathies.
WHAT WE DO
We support basic and clinical research, education, and standards of care in cooperation with patients and those developing treatments.
FEATURED NEWS & EVENTS
PNS Call for Abstracts - Submission Deadline 7 January 2022
We invite you to submit an abstract for our upcoming meeting in Miami, Florida. As the largest peripheral nerve meeting globally, this is the perfect opportunity for you to present your research, publish your work, and network with leaders in the peripheral nerve community. Click here to submit your abstract by 7 January.
2022 PNS Annual Meeting - Miami Website is Live!
We are excited to announce the launch of the 2022 PNS Annual Meeting – Miami website. It is a resource for the most up to date information on the 2022 Annual Meeting. Click here to view.
Available Now: EAN/PNS Guideline on Diagnosis and Treatment of CIDP
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision. Read the guideline here. For more information on the new CIDP guideline, please join us on 27 October for an open access webinar presented by Dr. Peter Van Den Bergh. Click here for more information and to register.
Introducing the PNS Quarterly Newsletter: The Nerve Connect
The Nerve Connect, the quarterly newsletter of the Peripheral Nerve Society, features the most current activities and initiatives of the Society, spotlights our members and their amazing work, and highlights exciting news in the field of peripheral. Click here to login to your PNS member account to read past issues!
COVID-19 Vaccine and Guillain-Barré Syndrome
Patients affected by inflammatory PNS disorders, most notably Guillain-Barre syndrome (GBS), and their physicians are making enquiries to the PNS membership about the merits of receiving a COVID vaccination. The following commentary on this complex issue has been recently published by a team of PNS members, led by Professor Michael Lunn, which summaries the current evidence surrounding vaccination and GBS: https://doi.org/10.1093/brain/awaa444. For additional information on COVID-19 vaccines and the GBS|CIDP community, please click here.
